ASX - By Stock
|
IBX |
Re:
Ann: Suspension from Quotation
|
|
whytee
|
32 |
16K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
32
|
16K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
whytee
|
18K |
10M |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
18K
|
10M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
whytee
|
536 |
196K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
536
|
196K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
whytee
|
24 |
3.7K |
0 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
24
|
3.7K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
whytee
|
3.1K |
1.3M |
5 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
3.1K
|
1.3M
|
5
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
whytee
|
11K |
5.9M |
8 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
11K
|
5.9M
|
8
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
whytee
|
18K |
10M |
3 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
18K
|
10M
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
whytee
|
369 |
124K |
0 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
369
|
124K
|
0
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
whytee
|
458 |
285K |
3 |
16/04/24 |
16/04/24 |
Charts
|
458
|
285K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024
|
|
whytee
|
34 |
7.2K |
7 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
34
|
7.2K
|
7
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024
|
|
whytee
|
34 |
7.2K |
4 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
34
|
7.2K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024
|
|
whytee
|
34 |
7.2K |
4 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
34
|
7.2K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024
|
|
whytee
|
34 |
7.2K |
8 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
34
|
7.2K
|
8
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024
|
|
whytee
|
34 |
7.2K |
5 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
34
|
7.2K
|
5
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024
|
|
whytee
|
34 |
7.2K |
4 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
34
|
7.2K
|
4
|
|
ASX - By Stock
|
OIL |
Re:
Good signs ....
|
|
whytee
|
243 |
88K |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
243
|
88K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
whytee
|
369 |
124K |
0 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
369
|
124K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
whytee
|
369 |
124K |
0 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
369
|
124K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
whytee
|
369 |
124K |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
369
|
124K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
whytee
|
369 |
124K |
1 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
369
|
124K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
whytee
|
369 |
124K |
0 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
369
|
124K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
whytee
|
369 |
124K |
2 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
369
|
124K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
whytee
|
11K |
5.9M |
7 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
11K
|
5.9M
|
7
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
whytee
|
11K |
5.9M |
11 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
11K
|
5.9M
|
11
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
whytee
|
11K |
5.9M |
16 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
11K
|
5.9M
|
16
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
whytee
|
369 |
124K |
4 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
369
|
124K
|
4
|
|
ASX - By Stock
|
OSL |
Re:
Ann: UK Private Insurer Approves Reimbursement for OncoSil
|
|
whytee
|
26 |
5.4K |
1 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
26
|
5.4K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Appoints John Han, PharmD, as VP Medical Affairs
|
|
whytee
|
9 |
2.3K |
8 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
9
|
2.3K
|
8
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
whytee
|
18K |
10M |
13 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
18K
|
10M
|
13
|
|
ASX - By Stock
|
OIL |
Re:
Good signs ....
|
|
whytee
|
243 |
88K |
0 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
243
|
88K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
The Clinicians Speak
|
|
whytee
|
886 |
330K |
14 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
886
|
330K
|
14
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
whytee
|
3.1K |
1.3M |
14 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
3.1K
|
1.3M
|
14
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
whytee
|
3.1K |
1.3M |
5 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
3.1K
|
1.3M
|
5
|
|
ASX - By Stock
|
3DA |
Re:
Ann: Investor Briefing Presentation
|
|
whytee
|
11 |
3.6K |
5 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
11
|
3.6K
|
5
|
|
ASX - By Stock
|
OIL |
Re:
Ann: Optiscan appoints US Clinical & Regulatory Heads
|
|
whytee
|
3 |
1.6K |
2 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
3
|
1.6K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
whytee
|
551 |
195K |
1 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
551
|
195K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
whytee
|
551 |
195K |
0 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
551
|
195K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
whytee
|
551 |
195K |
0 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
551
|
195K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
whytee
|
212 |
84K |
0 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
212
|
84K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
whytee
|
551 |
195K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
551
|
195K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Corporate Presentation - March 2024
|
|
whytee
|
40 |
14K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
40
|
14K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
Short Activity in PNV
|
|
whytee
|
6.7K |
2.0M |
2 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
6.7K
|
2.0M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
whytee
|
551 |
195K |
4 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
195K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
whytee
|
551 |
195K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
195K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
whytee
|
551 |
195K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
195K
|
1
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
whytee
|
18K |
10M |
14 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
18K
|
10M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
whytee
|
551 |
195K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
195K
|
1
|
|
ASX - By Stock
|
SLX Energy |
Re:
Nuclear Power Related Media Thread
|
|
whytee
|
4.7K |
1.9M |
2 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
4.7K
|
1.9M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
whytee
|
551 |
195K |
3 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
195K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
whytee
|
551 |
195K |
0 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
195K
|
0
|
|